2025/03/10
ÉùÃ÷£º±¾ÎÄ×ªÔØ×ÔIVDÑо¿Éç
¼ìÑéÊÖÒÕ£º¸ßͨÁ¿¡¢¾«×¼»¯¡¢¼´Ê±»¯
ÁÙ´²Ä¥Á·ÊÖÒÕ£¬£¬Õý³¯×ŸßͨÁ¿¡¢¾«×¼»¯¡¢¼´Ê±»¯Æ«ÏòÉú³¤£¬£¬½¹µãÁ¢Òì°üÀ¨ÂѰ×ø»îÐÔ¼ì²â¡¢ÊÊÅäÌå²âÐò¡¢ÒºÌå»î¼ì¼°AIÇý¶¯ÆÊÎö¡£¡£Î´À´Ç÷ÊÆ½«¾Û½¹¸ßΣÈËȺɸ²é¡¢ÊõÖÐʵʱÕï¶Ï¡¢µÍ±¾Ç®Ñ¬È¾²¡¼à²â£¬£¬ÒÔ¼°¶à×éѧÊý¾ÝÕûºÏ£¬£¬Íƶ¯¸öÐÔ»¯Ò½ÁƵÄÖÜÈ«Â䵨¡£¡£
£¨1£©¶íÀÕ¸Ô¿µ½¡Óë¿ÆÑ§´óѧ£¨OHSU£©¿ª·¢ÁË»ùÓÚÂѰ×ø»îÐÔµÄÐÂÐͼì²âÒªÁì PAC-MANN£¬£¬ÓÃÓÚ¸ßΣº¦ÈËȺ£¨ÈçÌÇÄò²¡»¼Õߣ©µÄÒÈÏÙ°©É¸²é¡£¡£¸ÃÊÖÒÕͨ¹ý´ÅÐÔÄÉÃ×´«¸ÐÆ÷²¶»ñѪҺÖеĻîÐÔMMPÂѰ×ø¼Ò×å³ÉÔ±£¬£¬¼ä½ÓÕÉÁ¿Ó«¹âÐźš£¡£ÔÚ»ØÊ×ÐÔÑéÖ¤ÖУ¬£¬PAC-MANN¶ÔÒÈÏÙ°©µÄÃô¸ÐÐÔ´ï73%£¬£¬ÌØÒìÐÔ´ï98%£¬£¬ÇÒÓëCA19-9ÁªÓú󣬣¬IÆÚ°©Ö¢¼ì²âÃô¸ÐÐÔÌáÉýÖÁ85%¡£¡£ÆäÓÅÊÆÔÚÓÚÎÞÐèÖØ´ó²âÐò£¬£¬±¾Ç®µÍ£¬£¬ÊÊÓÃÓÚ¸ßΣÈËȺµÄ°´ÆÚɸ²é¡£¡£
£¨2£©Ëþ·ò´Ä´óѧÑз¢µÄͼ°¸»¯¸ÉÔïѪ½¬µã¿¨ÓÅ»¯ÁËHIV²¡¶¾ÔØÁ¿¼ì²âµÄѪҺÑù±¾ÊÕÂÞ¡£¡£¸Ã×°±¸Í¨¹ýÈý²ãĤ½á¹¹£¨¾Ûõ¥¡¢¾Ûí¿¡¢ÏËÎ¬ËØ£©¸ßЧÊèɢѪ½¬£¬£¬ïÔ̺ìϸ°û×ÌÈÅ£¬£¬ÁÙ´²ÊÔµãÖÐ׼ȷÂÊ´ï91%£¬£¬ÓÅÓڹŰåÂÞÊÏѪ½¬¿¨£¨83%£©¡£¡£ÆäÊèË®À¯²ãÉè¼Æ¿É¿ØÖÆÑªÒºÁ÷¶¯Æ«Ïò£¬£¬ÌáÉýÑù±¾Ò»ÖÂÐÔ£¬£¬Î´À´»òÀ©Õ¹ÖÁÖ¬Öʼì²â¼°¼ÒÍ¥²ÉÑù¡£¡£
£¨3£©Atila Biosystems ÍÆ³ö BiodomeÊÖÒÕ£¬£¬Í¨¹ýÊèË®Äý½º¸ôÀëPCRÊÔ¼Á£¬£¬×èÖ¹ÔËÊäÎÛȾ£¬£¬²¢Ö§³Ö¸ßͨÁ¿¼ì²â¡£¡£¸ÃÊÖÒÕÔÚÂíÀïºÍÄáÈÕÀûÑǵÄHPVɸ²éÖÐʵÏÖÖðÈÕǧ´Î¼ì²â£¬£¬Ñ¸ËÙ¶È´ï95%£¬£¬±¾Ç®½öΪ6ÃÀÔª/´Î£¬£¬ÏÔÖø½µµÍÖеÍÊÕÈë¹ú¼ÒµÄ¹¬¾±°©É¸²éÃż÷¡£¡£
£¨4£©Å¦Ô¼´óѧÍŶӿª·¢µÄ³¬¿ìËÙÒºµÎÊý×ÖPCR£¨UR-ddPCR£©½«ÄÔÖ×ÁöÊÖÊõÖеķÖ×Ó¼ì²âʱ¼äËõ¶ÌÖÁ15·ÖÖÓ¡£¡£Í¨¹ýˢкËËáÌáÈ¡£¡£¨SwiftXÊÔ¼Á£©¡¢¼«¶ËPCR£¨¸ßŨ¶ÈÒýÎ¼°²»Ðâ¸Ö¹ÜÈÈÑ»·ÊÖÒÕ£¬£¬¸ÃÊÖÒÕ¿ÉÔÚÊõÖÐʵʱ¼ì²âIDH1ºÍBRAFÍ»±ä£¬£¬¸¨Öú¾«×¼ÇгýÖ×Áö½çÏߣ¬£¬²¢ÍýÏëÁ¬ÏµAIʵÏÖ×Ô¶¯»¯¡£¡£
£¨5£©°ÍÎ÷Ñо¿ÍŶÓʹÓÃÇâºË´Å¹²Õñ²¨Æ×£¨1H NMR£©ÆÊÎö173ÃûÔи¾ÑªÒºÑù±¾£¬£¬·¢Ã÷ÖØ¶È×ÓðïǰÆÚ»¼ÕßµÄÒÒËáÑΡ¢¹È°±õ£°·µÈ11ÖÖ´úлÎïˮƽÏÔÖøÉý¸ß£¬£¬ÌáÐѵª´úлºÍÄòËØÑ»·ÔÓÂÒ¡£¡£±ðµÄ£¬£¬ÑÖÜÓÎÀëDNA£¨cfDNA£©ÆÊÎöÊÖÒÕ£¨PEARL¿ò¼Ü£©Í¨¹ýÌ¥ÅÌÌØÒìÐÔÐòÁÐÕ¹Íû×ÓðïǰÆÚΣº¦£¬£¬×¼È·ÂÊ´ï85%£¬£¬Î´À´»òÕûºÏÖÁ²úǰɸ²éÁ÷³Ì¡£¡£
£¨6£©¿Ë¹Î÷´¢´óѧ¿ª·¢ÁË»ùÓÚ»îÐÔÑõ£¨ROS£©µÄÑ×Ö¢¼ì²âÒªÁ죬£¬Í¨¹ý¿¹Ìåʶ±ðÓë°ëë×°±ËáÁ¬ÏµµÄ»·Ñõͪʮ°ËÍéËᣨEKODE£©£¬£¬ÊµÏÖ×éÖ¯ÌØÒìÐÔÑ×Ö¢±ê¼ÇÎï¼ì²â¡£¡£¸ÃÊÖÒÕ¿ÉÇø·ÖÉñÔಡ¡¢°¢¶û´Äº£Ä¬²¡µÈÑ×Ö¢Ïà¹Ø¼²²¡£¬£¬²¢ÓÐÍûÍÆ¶¯Ò©Îï°Ðµã·¢Ã÷¡£¡£
£¨7£©Î÷ÄÎɽÒÁ¿²Ò½Ñ§ÔºÊ¹ÓÿÉÒÂ×Å×°±¸£¨ÈçApple Watch£©Ò»Á¬¼à²âÑ×Ö¢ÐÔ³¦²¡£¡£¨IBD£©»¼Õߵľ²Ï¢ÐÄÂÊ¡¢ÑªÑõ¼°ÐÄÂʱäÒìÐÔ£¬£¬·¢Ã÷Ñ×Ö¢±¬·¢Ç°7ÖÜÐÄÀíÖ¸±êÒì³££¬£¬AIËã·¨ÕýÓÃÓÚÕ¹Íû¼²²¡»î¶¯ÆÚ¡£¡£
£¨8£©Å£½ò´óѧµÄ TriOxÒºÌå»î¼ìÁ¬ÏµTAPSÈ«»ùÒò×éDNA²âÐòÓë»úеѧϰ£¬£¬¼ì²â½áÖ±³¦°©¡¢ÒÈÏÙ°©µÈ6ÖÖÔçÆÚ°©Ö¢£¬£¬Ñ¸ËÙ¶È94.9%£¬£¬ÌØÒìÐÔ88.8%¡£¡£Æä½¹µãΪÆÊÎöÑ»·Ö×ÁöDNA£¨ctDNA£©µÄ¼×»ù»¯¼°Æ¬¶Ï»¯ÌØÕ÷£¬£¬ÍýÏëÔÚ¸ßΣÈËȺÖнøÒ»²½ÑéÖ¤¡£¡£
£¨9£©Æ¥×ȱ¤´óѧÓëReligenDxÏàÖú¿ª·¢Ë«ÉúÎï±ê¼ÇÎï¼ì²â£¨CA19-9/STRA£©£¬£¬ÓÃÓÚÒÈÏÙ°©É¸²é£¬£¬Ãô¸ÐÐÔÌáÉýÖÁ71%£¬£¬¼ÙÑôÐÔÂʵÍÓڹŰåCA19-9¡£¡£CLIAʵÑéÊÒÕýÍÆ½øÁÙ´²ÑéÖ¤£¬£¬Ä¿µÄÁýÕÖÒÅ´«¸ßΣº¦ÈËȺ¡£¡£
£¨10£©¶àÂ×¶à´óѧµÄsmol-seqƽ̨ʹÓÃDNAÊÊÅäÌåÁ¬Ïµ´úлÎï²¢ÊÍ·ÅÌõÐÎÂ룬£¬Í¨¹ý²âÐòʵÏÖÌÇÀà¡¢¼¤ËصÈС·Ö×ӵĸßͨÁ¿¼ì²â¡£¡£ÆäѸËÙ¶ÈæÇÃÀÖÊÆ×£¬£¬µ«±¾Ç®¸üµÍ¡¢ËÙÂʸü¿ì£¬£¬Î´À´»òÀ©Õ¹ÖÁǧÖÖ´úлÎïͬ²½ÆÊÎö£¬£¬²¢ÕûºÏ»úеѧϰÓÅ»¯ÊÊÅäÌåÉè¼Æ¡£¡£
£¨11£©Ó¢¹úGenomics England µÄ¡°10Íò»ùÒò×éÍýÏ롱½«È«»ùÒò×é²âÐò£¨WGS£©ÄÉÈëNHSͨÀýÁÙ´²Êµ¼ù£¬£¬ÁýÕÖ°©Ö¢ÓëÓÐÊý²¡¡£¡£ÃÀ¹ú GUARDIANÑо¿¶Ô10ÍòÐÂÉú¶ù¾ÙÐÐWGS¸¨Öúɸ²é£¬£¬·¢Ã÷¹Å°åÒªÁì©ÕïµÄÒÅ´«²¡£¬£¬µ«ÐèÆ½ºâ±¾Ç®ÓëÂ×ÀíÎÊÌâ¡£¡£
£¨12£©Genomenon¹«Ë¾Í¨¹ýAIÕûÀí2700Íò±äÒìÊý¾Ý¿â£¬£¬¼ÓËÙÁÙ´²»ùÒò×é½â¶Á£¬£¬½â¾öNGSÊý¾ÝµÄ¡°ÉúÎïÐÅϢѧƿ¾±¡±£¬£¬ÒÑÓë2000¼ÒʵÑéÊÒÏàÖú¡£¡£
£¨13£©Carna Health ÕûºÏNova BiomedicalµÄ±ãЯװ±¸ÓëAIÆÊÎö£¬£¬ÊµÏÖ¼¡ôû¡¢eGFRµÈÖ¸±êµÄ¼´Ê±¼ì²â£¨POCT£©£¬£¬ÁýÕÖÒ½ÔºÍⳡ¾°¡£¡£Æäƽ̨Á¬ÏµÇøÓò»¯Êý¾ÝÓÅ»¯Î£º¦ÆÀ¹À£¬£¬Ä¿µÄ½â¾öÈ«Çò90% CKD©ÕïÎÊÌâ¡£¡£
£¨14£©±öϦ·¨ÄáÑÇÖÝÁ¢´óѧ¿ª·¢±ãЯʽÎÞÏß×°±¸£¬£¬Í¨¹ý¼¤¹âÓÕµ¼Ê¯Ä«Ï©´«¸ÐÆ÷ͬ²½¼ì²âSARS-CoV-2ºÍάÉúËØC£¬£¬Ñ¸ËÙ¶ÈÌáÉý2±¶£¬£¬Ð§¹û15·ÖÖÓ´«ÊäÖÁÊÖ»ú£¬£¬±¾Ç®µÍÁ®£¬£¬ÊÊÓÃÓÚ¼ÒÍ¥¿µ½¡ÖÎÀí¡£¡£
8´óÁìÓòÐÂÆ·»ñÅúÉÏÊУº¶àÔª»¯
IVDÁìÓòÐÂÆ·Æµ³ö£¬£¬¾Û½¹¾«×¼»¯¡¢¼´Ê±»¯¡¢¼ÒÍ¥»¯Èý´óÇ÷ÊÆ¡£¡£°©Ö¢ÅãͬÕï¶ÏÏò³¬µÍ±í´ï°Ð±êÑÓÉ죨ÈçHER2-ultralow£©£¬£¬Çý¶¯¸öÌ廯ÖÎÁÆ£»£»£»Ñ¬È¾ÐÔ¼²²¡¼ì²âÀ©Õ¹¶àÖØPCRÓëÄÍÒ©ÐÔÆÊÎö£¬£¬Ó¦¶ÔÈ«Çò¹«¹²ÎÀÉúÌôÕ½£»£»£»¼ÒÍ¥×Ô¼ìÓëPOCT ×°±¸£¨ÈçImpress²ÉѪÆ÷¡¢Simpli-Collect STI£©ÌáÉýÕï¶Ï¿É¼°ÐÔ£»£»£»AIÓë΢Á÷¿ØÊÖÒÕ¸³ÄܸßѸËÙ¶È¡¢µÍ±¾Ç®Æ½Ì¨£¨ÈçCubitDx£©£¬£¬ÖØËÜ×ÊÔ´ÓÐÏÞµØÇøÒ½ÁÆÃûÌᣡ£
£¨1£©Visby Medical µÄºôÎü¿µ½¡¼ì²â»ñFDA 510(k)¼°CLIA¿íÃ⣬£¬³ÉΪÊ׸ö»ùÓÚRT-PCRµÄ¼´Ê±¼ì²â£¨POCT£©£¬£¬¿ÉÔÚ30·ÖÖÓÄÚ¼ì²â±ÇÊÃ×ÓÑù±¾ÖеÄSARS-CoV-2¡¢Á÷¸ÐA/B²¡¶¾RNA¡£¡£¸Ã¼ì²âÊÊÓÃÓÚ×ÊÔ´ÓÐÏÞµÄÒ½ÁƳ¡¾°£¨ÈçÔ¶³ÌÕïËù£©£¬£¬ÖúÁ¦¿ìËÙÕï¶ÏÓëÖÎÁƾöÒé¡£¡£´Ëǰ£¬£¬¸Ã²úÆ·ÓÚ2022Äê12Ô»ñFDA½ôÆÈʹÓÃÊÚȨ£¨EUA£©¡£¡£
£¨2£©ÂÞÊÏÕï¶ÏÍÆ³öCobas Liat CT/NG/MG¼ì²â£¬£¬»ñFDA 510(k)¼°CLIA¿íÃ⣬£¬¿ÉÔÚ20·ÖÖÓÄÚͨ¹ýPCRͬʱ¼ì²âɳÑÛÒÂÔÌå¡¢Áܲ¡ÄÎɪ¾úºÍÉúÖ³Ö§ÔÌ壬£¬ÊÊÓÃÓÚÉçÇøÒ½ÁƳ¡¾°£¬£¬ïÔÌ¿¹ÉúËØÀÄÓò¢×èÖ¹ÐÔÈö²¥Ñ¬È¾£¨STI£©Èö²¥¡£¡£
£¨3£©Cepheid µÄXpert Xpress Cov-2/Flu/RSV Plus ºÍ Xpert Xpress CoV-2 Plus ¼ì²â»ñFDAÅú×¼£¬£¬À©Õ¹ÖÁGeneXpert Xpressϵͳ£¬£¬Ö§³Ö±ÇÑÊ/ǰ±ÇÊÃ×ÓÑù±¾ÖÐSARS-CoV-2¡¢Á÷¸ÐA/B¼°RSVµÄ¿ìËÙÅбðÕï¶Ï¡£¡£
£¨4£©ÂÞÊÏÕï¶ÏµÄPathway Anti-HER2/neu (4B5)¿¹Ìå¼ì²â»ñFDAÅú×¼×÷Ϊ Enhertu£¨ÇúÍ×Öéµ¥¿¹deruxtecan£©µÄÅãͬÕï¶Ï£¬£¬ÓÃÓÚʶ±ðHER2-ultralow×ªÒÆÐÔÈéÏÙ°©»¼Õߣ¨±í´ïˮƽµÍÓÚHER2µÍ״̬£©¡£¡£¸Ã¼ì²âÁ¬ÏµBenchMark IHC/ISHȾɫÒÇ£¬£¬±ê×¼»¯ÃâÒß×黯Á÷³Ì£¬£¬ÌáÉýÕï¶Ï׼ȷÐÔ¡£¡£
£¨5£©OncoAssure ÔÚÃÀ¹úÍÆ³öʵÑéÊÒ¿ª·¢µÄǰÏßÏÙ°©Ô¤ºó¼ì²â£¬£¬Í¨¹ýqPCR¼ì²âFOXM1µÈ4¸öÇý¶¯»ùÒò¼°2¸ö²Î¿¼»ùÒò£¬£¬Á¬ÏµÁÙ´²Êý¾ÝÉúÒòËØ×ÓÁÙ´²Î£º¦ÆÀ·Ö£¨MCRS£©£¬£¬ÓÅ»¯»¼Õ߷ֲ㡣¡£¸Ã¼ì²âÍýÏëͨ¹ýDiaCartaÏàÖúÉÌÒµ»¯£¬£¬²¢×·ÇóFDAÊÔ¼ÁºÐ°æ±¾Åú×¼¡£¡£
£¨6£©MRC HollandµÄSALSA MLPAÈéÏÙ°©/Âѳ²°©×ÛºÏÕ÷¼ì²â»ñCE-IVDRÈÏÖ¤£¬£¬»ùÓÚ¶àÖØÅþÁ¬ÒÀÀµÐÔ̽ÕëÀ©Ôö£¨MLPA£©ÊÖÒÕ£¬£¬¼ì²âBRCA1/2»ùÒò¿½±´Êý±äÒ죬£¬ÁýÕÖ350ÓàÖÖ̽Õ룬£¬³ÉΪÒÅ´«ÐÔ°©Ö¢Õï¶ÏµÄ½ð±ê×¼¡£¡£
£¨7£©ÑÅÅàAlere NT-proBNP¼ì²â»ñFDAÅú×¼£¬£¬ÓÃÓÚ¶¨Á¿ÑªÇå/Ѫ½¬ÖÐN×îºóBÐÍÀûÄÆëÄǰÌ壬£¬¸¨ÖúÕï¶Ïз¢»ò¶ñ»¯ÐÄÁ¦Ë¥½ß¡£¡£¸Ã¼ì²â¼¯³ÉÓÚAlinity Iϵͳ£¬£¬ÍêÉÆÐÄÔಡ¼ì²â²Ëµ¥¡£¡£
£¨8£©AliveDxµÄMosaiQ AiPlex CTDplus¶àÖØ¼ì²â»ñCE-IVDRÈÏÖ¤£¬£¬¿Éͬʱ¼ì²â15ÖÖ×ÔÉí¿¹Ì壨È翹dsDNA¡¢Sm/RNP£©£¬£¬ÓÃÓÚϵͳÐÔºì°ßÀÇ´¯¡¢Àà·çʪÐÔÊàŦÑ×µÈÈ«ÉíÐÔ×ÔÉíÃâÒßÐÔ·çʪ²¡£¡£¨SARD£©Õï¶Ï¡£¡£¸Ãƽ̨ÒÑÀÛ¼Æ5ÏîCE-IVDRÈÏÖ¤¡£¡£
£¨9£©WerfenµÄAptiva¿¹Á×Ö¬×ÛºÏÕ÷£¨APS£©ÊÔ¼Á»ñFDA 510(k)Åú×¼£¬£¬°ë¶¨Á¿¼ì²â¿¹ÐÄÁ×Ö¬£¨aCL£©ºÍ¿¹¦Â2ÌÇÂѰ×1£¨a¦Â2GP1£©¿¹Ì壬£¬8СʱÄÚ¿ÉÍê³É960¸ö²âÊÔ£¬£¬ÌáÉý×ÔÉíÃâÒß²¡Õï¶ÏЧÂÊ¡£¡£
£¨10£©Revvity×Ó¹«Ë¾EuroimmunÀ©Õ¹Õæ¾ú¼ì²â²Ëµ¥£¬£¬ÍƳöEuroArrayƤ·ôÕæ¾ú²¡¼ì²â£¨2024Äê¸üа棩£¬£¬¿É¼ì²â71ÖÖÕæ¾ú£¨º¬ÄÍÒ©¾úÖ꣩£¬£¬²¢¿ª·¢»ùÓÚPCRµÄ¶úÄîÖé¾ú¼°Çúù¾ú¼ì²â£¬£¬Ó¦¶Ô¿¹Õæ¾úÄÍÒ©ÐÔÌôÕ½¡£¡£
£¨11£©InflammatixµÄTriVerityŧ¶¾Ö¢¼ì²â»ñFDAÅú×¼£¬£¬Í¨¹ýRT-LAMPÊÖÒÕ30·ÖÖÓÄÚÕÉÁ¿ËÞÖ÷·´Ó¦»ùÒò±í´ï£¬£¬Çø·ÖѬȾÐÔÓë·ÇѬȾÐÔ¼²²¡£¬£¬²¢ÆÀ¹À²¡ÇéÏ£ÍûΣº¦¡£¡£
£¨12£©LiofilchemµÄÍ·æß±ÈÆÕÒ©Ãô¼ì²â»ñFDAÅú×¼£¬£¬¶¨Á¿²â¶¨´ó³¦¸Ë¾ú¡¢½ð»ÆÉ«ÆÏÌÑÇò¾úµÈ¶ÔÍ·æß±ÈÆÕµÄ×îµÍÒÖ¾úŨ¶È£¨MIC£©£¬£¬Ö§³Ö¿¹¾úÒ©ÎïºÏÀíʹÓᣡ£
£¨13£©LetsGetCheckedµÄImpress²ÉѪװÖûñFDA 510(k)ÔÊÐí£¬£¬½ÓÄÉÕæ¿ÕÊÖÒÕÊÕÂÞ΢Éý¼¶È«ÑªÑù±¾£¬£¬ïÔÌÈÜѪΣº¦£¬£¬ÊÊÓÃÓÚרҵ³¡¾°¡£¡£¸Ã×°±¸Ôø»ñ2024ºìµãÉè¼Æ½±£¬£¬Ö§³Ö¼ÒÍ¥¼°ÁÙ´²POCTÇéÐΡ£¡£
£¨14£©ÑÅÅàµÄSimpli-Collect STI¼ì²â»ñFDAÅú×¼£¬£¬ÔÊÐí»¼Õß¾Ó¼Ò×Ô²ÉÄòÒº/ÒõµÀÊÃ×ÓÑù±¾£¬£¬ÓʼÄÖÁʵÑéÊÒ¼ì²âÒÂÔÌå¡¢Áܲ¡¡¢µÎ³æ¼°ÉúÖ³Ö§ÔÌ壬£¬ÐèÒ½Éú´¦·½£¬£¬À©Õ¹STIɸ²é¿É¼°ÐÔ¡£¡£
£¨15£©Cubit Diagnostics »ñNIH 260ÍòÃÀÔªRADx×ÊÖú£¬£¬¿ª·¢ CubitDx¶àģʽÕï¶Ïƽ̨£¬£¬ÕûºÏ³¬¿ìËÙPCRÓë΢Á÷¿ØÊÖÒÕ£¬£¬15·ÖÖÓÄÚ¼ì²âCOVID-19/Á÷¸ÐA/B£¬£¬Ñ¸ËÙ¶ÈæÇÃÀʵÑéÊÒ¼ì²â£¬£¬±¾Ç®µÍÁ®£¬£¬Î´À´¿ÉÀ©Õ¹ÖÁ°ÜѪ֢¡¢ÐÔ²¡µÈÁìÓò¡£¡£
£¨16£©AlterDiagÓë°Í˹µÂÑо¿ËùÏàÖú¿ª·¢Ñ¬È¾²¡¿ìËÙ¼ì²â£¬£¬Ê¹Óõ¥Óò¿¹ÌåÌáÉýѸËÙ¶È£¬£¬Ê×ÅúÏîÄ¿¾Û½¹WHOÖØµã²¡ÔÌ壬£¬»ñ200ÍòÅ·ÔªÖÖ×Ó×ʽðÖ§³Ö¡£¡£
£¨17£©Euroimmun¼ÓÈëUTI-DiagÏîÄ¿£¨Å·ÃË×ÊÖú470ÍòÃÀÔª£©£¬£¬¿ª·¢Äò·ѬȾ£¨UTI£©·ÖÕïÊÔÖ½¡¢POCTÒÇÆ÷¼°Êý×ÖÆ½Ì¨£¬£¬ÍýÏë2028ÄêÔÚ·ÇÖÞÍÆ¹ã£¬£¬½â¾ö¿¹ÉúËØÀÄÓÃÎÊÌâ¡£¡£
£¨18£©ÂÞÊÏÕï¶ÏµÄElecsys sFlt-1/PlGF±ÈÖµ¼ì²â»ñFDA 510(k)Åú×¼£¬£¬Í¨¹ýÕÉÁ¿Ñª¹ÜÌìÉú±ê¼ÇÎsFlt-1ÓëPlGF£©Õ¹Íû×ÓðïǰÆÚΣº¦£¬£¬¸¨ÖúסԺÔи¾·Ö²ãÖÎÀí£¬£¬½µµÍÔç²ú¼°Æ÷¹ÙËðÉËΣº¦¡£¡£
ÈÚ×Ê»îÔ¾£ºÁè¼Ý8.66ÒÚÔªÈËÃñ±Ò
2Ô·ݣ¬£¬ÍâÑóIVDÐÐÒµ·ºÆð³öÇ¿¾¢µÄÈÚ×ÊÊÆÍ·£¬£¬·ºÆð¡°ÊÖÒÕÇý¶¯¡¢¿ç½çÈںϡ¢È«Çò»¯¡±Èý´óÌØÕ÷¡£¡£ÈÚ×ÊÖ÷ÒªÓÃÓÚÊÖÒÕÑз¢¡¢Æ½Ì¨ÓÅ»¯¡¢Êг¡À©Õ¹¡¢Ð²úÆ·¿ª·¢¼°È˲ÅÕÐÆ¸µÈ·½Ãæ¡£¡£ÒºÌå»î¼ì¡¢µ¥Ï¸°ûÆÊÎö¡¢AIÕï¶ÏÓëPOCTÊÇÄ¿½ñ×ÊÔ´¹Ø×¢½¹µã¡£¡£Î´À´£¬£¬Ëæ×Åî¿ÏµÉóÅúÍÆ½ø£¨ÈçFDA¡¢CE-IVD£©¼°ÐÂÐËÊг¡ÉøÍ¸£¬£¬IVDÊÖÒÕÓÐÍûÔÚ°©Ö¢Ôçɸ¡¢Ñ¬È¾²¡·À¿ØÓ뾫׼ҽÁÆÖÐʩչ¸ü×ÅÊöÓᣡ£2ÔÂÈÚ×ÊÊÂÎñ¹²ÓÐ12´Î£¬£¬ÈÚ×ʽð¶îԼΪ1.186ÒÚÃÀÔª£¨Ô¼8.66ÒÚÔªÈËÃñ±Ò£©¡£¡£
£¨4£©Renovaro ͨ¹ý1500ÍòÃÀÔª¹ÉȨÈÚ×ʼ°ÓëBioSymetricsºÏ²¢£¬£¬¼ÓËÙAIƽ̨ÔÚ°©Ö¢¼ì²âÓëÒ©Îï·¢Ã÷ÖеÄÓ¦Óᣡ£ÆäÊÖÒÕÁ¬Ïµ¶à×éѧÆÊÎöºÍ²î±ð·Ö×ÓÕï¶Ï£¬£¬ÁýÕÖ2600+ÉúÎï±ê¼ÇÎ£¬Ä¿µÄÊÇÔڹŰåÒªÁìǰʶ±ð°©Ö¢¡£¡£
£¨5£©Dxcover »ñ620ÍòÃÀÔªÖ§³ÖÆä¶à×éѧ¹âÆ×ÆÊÎö£¨MOSA-Dx£©Æ½Ì¨£¬£¬Í¨¹ýAIËã·¨¼ì²âʵÌåÁö£¬£¬ÍýÏëÔÚÃÀ¹úÄÉʲά¶ûÉèÁ¢×ܲ¿ÒÔÍÆ¶¯ÉÌÒµ»¯¡£¡£
£¨10£©Kryptos Biotechnologies »ñOsang Healthcare×·¼Ó200ÍòÃÀԪͶ×Ê£¬£¬¿ª·¢20·ÖÖÓ¿ìËÙqPCR¼ì²âϵͳ£¨Kuick£©£¬£¬ÁýÕÖÐÔÈö²¥¼²²¡ÓëºôÎüµÀ²¡ÔÌ壬£¬ÍýÏëÌá½»FDAÉóÅú¡£¡£
£¨11£©Cubit Diagnostics »ñNIH 260ÍòÃÀÔª×ÊÖú£¬£¬Íƽø¸ßѸËÙ¶È¡¢µÍ±¾Ç®¶àģʽÕï¶Ïƽ̨£¬£¬ÕûºÏ³¬¿ìËÙPCRÓë΢Á÷¿ØÊÖÒÕ£¬£¬Ä¿µÄÔÚ15·ÖÖÓÄÚÌṩʵÑéÊÒ¼¶Ð§¹û£¬£¬ÁýÕÖCOVID-19¡¢Á÷¸Ð¼°Î´À´°ÜѪ֢µÈ³¡¾°¡£¡£
£¨12£©Gravity Diagnostics »ñ500ÍòÃÀԪͶ×Ê£¬£¬À©Õ¹¶¾Àíѧ¡¢Ò©Îï»ùÒò×éѧµÈ¼ì²âЧÀÍ£¬£¬Í¨¹ýÔöǿʵÑéÊÒÄÜÁ¦ÁýÕÖÈ«ÃÀÒ½ÁÆ»ú¹¹¡£¡£
£¨13£©OSANG Healthcare Ò»Á¬½á¹¹ÑªÌÇÓë°©Ö¢Õï¶Ï´«¸ÐÆ÷£¬£¬ÍýÏëͨ¹ýÔ¶³ÌÕï¶ÏϵͳʵÏÖ¡°Ò½ÁÆ×°±¸¼Òµç»¯¡±£¬£¬²úÆ·Òѳö¿Ú110¶à¸ö¹ú¼Ò¡£¡£
£¨14£©RenovaroÓëBioSymetricsºÏ²¢£¬£¬ÕûºÏºóÕßAIÇý¶¯µÄElionƽ̨£¬£¬ÔöÇ¿ÉúÎï±ê¼ÇÎïÊý¾Ý¿âÓëÒ©Îï·¢Ã÷ЧÂÊ£¬£¬Ä¿µÄ2025ÄêÍê³ÉÉúÒâ¡£¡£
£¨15£©Ginkgo BioworksÁªºÏTGenµÈ»ñÅ·ÃË2400ÍòÅ·Ôª×ÊÖú£¬£¬¿ª·¢»ùÓÚCRISPRÓëNGSµÄPOCºôÎüµÀ²¡ÔÌå¼ì²â£¨RANGER£©£¬£¬ÍýÏë2025ÄêʵÏÖ6СʱÖÜתµÄ×Ô¶¯»¯×°±¸¡£¡£
£¨16£©Oncocyte ͨ¹ý2910ÍòÃÀÔª¹ÉȨÈÚ×ÊÍÆ½øÒÆÖ²¼à²â¼ì²â£¨VitaGraft Kidney£©µÄFDAÉóÅú£¬£¬¸Ã¼ì²â»ùÓÚddPCRÊÖÒÕ£¬£¬ÒÑ»ñÃÀ¹úÒ½±£ÁýÕÖ¡£¡£
£¨17£©Oxford Cancer Analytics ÓëÈ«Çò·Î°©É¸²éÏîÄ¿ÏàÖú£¬£¬ÑéÖ¤ÆäÂѰ×ÖÊ×éѧ¼ì²âµÄÁÙ´²Ð§Ó㬣¬Í¬Ê±½á¹¹CLIAʵÑéÊÒÓëFDAÉ걨¡£¡£
£¨20£©Å·ÖÞ£ºÅ·ÃËͨ¹ýEU4HealthÍýÏëÖ§³ÖPOCÊÖÒÕ¿ª·¢£¬£¬Ó¢¹úDxcoverÓëÁ¢ÌÕÍðAtrandiÆð¾¢ÍØÕ¹ÃÀ¹úÓëÑÇÖÞÊг¡¡£¡£
²¢¹ºÕûºÏ£º³¬800ÒÚÈËÃñ±Ò
ÁíÍ⣬£¬IVDÐÐÒµ²¢¹ºÕûºÏ»î¶¯ÆµÈÔ£¬£¬ÖÚ¶àÆóҵͨ¹ýÊÕ¹º¡¢·Ö²ðµÈ·½·¨ÓÅ»¯×ÊÔ´ÉèÖ㬣¬ÔÚÊÖÒÕ»¥²¹¡¢Êг¡ÍØÕ¹¡¢²úÆ·Ï߸»ºñ¡¢ÐÐÒµÕûºÏµÈ·½ÃæµÄÆð¾¢Ç÷ÊÆ£¬£¬ÔöÇ¿×ÔÉí¾ºÕùÁ¦£¬£¬ÍØÕ¹ÓªÒµÁìÓò¡£¡£×ܼƲ¢¹ºÊÂÎñ11´Î£¬£¬ÆäÖÐ9´ÎÅû¶ÁËÏêϸµÄ²¢¹º½ð¶î£¬£¬×ܽð¶îԼΪ110.4ÒÚÃÀÔª£¨Ô¼806ÒÚÔªÈËÃñ±Ò£©¡£¡£
£¨1£©ÈüĬ·ÉÊÀ¶ûÊÕ¹ºSolventum£ºÈüĬ·ÉÊÀ¶ûÒÔÔ¼41ÒÚÃÀÔªÏÖ½ðÊÕ¹ºSolventumµÄ´¿»¯Óë¹ýÂËÓªÒµ£¬£¬¸ÃÓªÒµÊÇÉúÎïÖÆÆ·Éú²úÒÔ¼°Ò½ÁÆÊÖÒպ͹¤ÒµÓ¦ÓÃÖÐʹÓõĴ¿»¯ºÍ¹ýÂËÊÖÒÕµÄÁìÏȹ©Ó¦ÉÌ¡£¡£´Ë´ÎÊÕ¹ºÓëÈüĬ·ÉÊÀ¶ûÏÖÓеÄÉúÎïÉú²ú²úÆ·×éºÏ¸ß¶È»¥²¹£¬£¬ÓÐÖúÓڸù«Ë¾ÔÚ¹ýÂËÖÖ±ðÖд¦ÓÚ¸üÓÐÀûµÄְ룬£¬ÔöÇ¿ÆäÔÚÉÏÓκÍÏÂÓÎÉúÎ﹤ÒÕÊÂÇéÁ÷³ÌÖеÄÄÜÁ¦¡£¡£
£¨2£©á⿨ÏÔ΢ϵͳ¹«Ë¾ÊÕ¹ºATTO-TEC£ºá⿨ÏÔ΢ϵͳ¹«Ë¾ÊÕ¹ºÁËÓ«¹âȾÁϺÍÊÔ¼Á¹©Ó¦ÉÌATTO-TEC£¬£¬Í¨¹ýÕûºÏATTO-TECµÄ¸ßÖÊÁ¿Ó«¹âȾÁϺÍÊÔ¼Á£¬£¬ÔöÇ¿ÁËá⿨µÄÏÔ΢¾µ³ÉÏñÊÂÇéÁ÷³Ì£¬£¬Ñо¿Ö°Ô±½«ÊÜÒæÓÚÓÅ»¯µÄ¼ì²âºÍȾÁÏ¿ª·¢£¬£¬´Ó¶ø¸ÄÉÆ°©Ö¢Ñо¿µÈÁìÓòµÄÖØ¶È3D³ÉÏñ¡£¡£
£¨3£©Bio-RadÊÕ¹ºStilla Technologies£ºÒÔ2.25ÒÚÃÀÔªÏֽ𣬣¬5ÍòÍòÃÀÔªÀï³Ì±®¸¶¿îÊÕ¹º¡£¡£Ö¼ÔÚÔö²¹Bio-RadÏÖÓеÄÊý×ÖPCR²úÆ·×éºÏ²¢¼ÓËÙÏÂÒ»´úÊý×ÖPCR½â¾ö¼Æ»®µÄ¿ª·¢¡£¡£StillaµÄÏÂÒ»´úÊý×ÖPCR½â¾ö¼Æ»®½«³ÉΪBio-RadÒ»Á÷µÄÊý×ÖPCR²úÆ·×éºÏµÄÒýÈËעĿµÄÔö²¹£¬£¬Ö§³ÖÆäÕ½ÂÔ£¬£¬½øÒ»²½½«ÓªÒµÀ©Õ¹µ½Ó¦ÓÃÑо¿ºÍÁÙ´²Õï¶ÏÁìÓò¡£¡£
2.ÓªÒµ·Ö²ðÓëÕ½ÂÔµ÷½â
£¨4£©BDÐû²¼½«´ÓÆäÉúÎï¿ÆÑ§ºÍÕï¶Ï²¿·Ö²ð·Ö£ºBDÌåÏÖ£¬£¬Ëü½«°ÑÉúÎï¿ÆÑ§ºÍÕï¶Ï²¿·Ö´ÓÆäÒ½ÁÆÊÖÒÕÓªÒµÖÐÊèÉ¢³öÀ´£¬£¬µ«ÊèÉ¢µÄÐÎʽÈÔÓдý¾öÒé¡£¡£Ê×ϯִÐйÙTom PolenÔڲƱ¨µç»°¾Û»áÉÏÌåÏÖ£¬£¬¸Ã¹«Ë¾»¹½«¡°¼Ó±¶Æð¾¢¡±£¬£¬Í¨¹ýºÏ²¢²¢¹º½«ÆäͶ×Ê×éºÏ×ªÒÆµ½¸ßÔöÌíÁìÓò¡£¡£
£¨5£©·ÑÉÓÈ˹ҽÁƹ«Ë¾³öÊÛʵÑéÊÒ×ʲú¸øQuest Diagnostics£ºÊÕ¹ºÔ¤¼Æ½«ÓÚ2025ÄêϰëÄêÍê³É£¬£¬µ«ÊÜÓ°ÏìЧÀ͵Ĺý¶ÉÆÚÔ¤¼Æ½«ÑÓÉìÖÁ2026ÄêÍ·¡£¡£´Ë´ÎÊÕ¹ºÎªQuestÌṩÁ˲âÊÔ͸ÎöÓÃË®ÖÊÁ¿µÄÐÂÄÜÁ¦£¬£¬·ÑÉÓÈ˹ϣÍûÌá¸ßÔËӪЧÂÊ£¬£¬²¢Ê¹ÓÃQuestµÄÂýÐÔÉö²¡ºÍÒÆÖ²Ð§ÀÍÒÔ¼°QuestµÄÃÀ¹úʵÑéÊÒÍøÂç¡£¡£
£¨9£©Tempus AIÊÕ¹ºAmbry Genetics£ºTempus AI´ÓÁíÀàͶ×ÊÖÎÀí¹«Ë¾Ares ManagementÌØÊâ³ï¼¯ÁË3ÒÚÃÀÔªµÄÔöÁ¿Õ®ÎñÈÚ×Ê¡£¡£AmbryÊÇÒÅ´«ÐÔ°©Ö¢É¸²éµÄÏòµ¼Õߣ¬£¬´Ë´ÎÊÕ¹º½«ÎªTempusÌṩ¸ü´óµÄÒÅ´«ÐÔ°©Ö¢Î£º¦¼ì²âÄÜÁ¦£¬£¬²¢Ôö²¹ÆäʹÓÃÊý¾ÝÍÆ½øÁÙ´²ºÍ¿ÆÑ§Á¢ÒìµÄÕ½ÂÔ¡£¡£
£¨10£©QuanterixÊÕ¹ºAkoya Biosciences£ºÐû²¼ÁËÒ»Ïî×îÖպϲ¢ÐÒ飬£¬Quanterix½«ÒÔÈ«¹ÉƱÉúÒâ·½·¨ÊÕ¹ºAkoya¡£¡£´Ë´ÎÊÕ¹º½«½¨ÉèµÚÒ»¸ö»ùÓÚѪҺºÍ×éÖ¯µÄÂѰ×ÖÊÉúÎï±ê¼ÇÎïµÄ³¬Ñ¸ËÙ¼ì²â¼¯³É½â¾ö¼Æ»®£¬£¬½«AkoyaµÄ×éÖ¯¿Õ¼äÉúÎïѧÄÜÁ¦ÓëQuanterixÓÃÓÚ³¬Ñ¸ËÙ¼ì²âѪҺÖÐÉúÎï±ê¼ÇÎïµÄÏȽø¹¤¾ßÏàÁ¬Ïµ¡£¡£
ÖØµãÈüµÀ£º²¡Àí¡¢AD¡¢²âÐò
Ò»£¬£¬²¡ÀíÕï¶Ï
IVD²¡ÀíÕï¶ÏÊг¡ÕýÂÄÀú¡°AI»¯¡¢Æ½Ì¨»¯¡¢¾«×¼»¯¡±×ªÐÍ¡£¡£Ö»¹Ü¸ß±¾Ç®ÓëÁ÷³Ì¹ßÐÔÈÔÊÇÖ÷ÒªÌôÕ½£¬£¬µ«ÊÖÒÕÍ»ÆÆ£¨Èç»ù´¡Ä£×Ó¡¢¶àÆ÷¹Ù¼ì²â£©Óëî¿ÏµÖ§³Ö£¨FDAÈÏÖ¤£©ÎªÐÐÒµ×¢È붯Á¦¡£¡£Î´À´£¬£¬Í¨¹ý¿çÁìÓòÏàÖú£¨ÆóÒµ-ѧÊõ-ÊÖÒÕ¹©Ó¦ÉÌ£©ÓëÁÙ´²¼ÛÖµÑéÖ¤£¬£¬Êý×Ö²¡ÀíѧÓÐÍûÔÚ°©Ö¢ÕïÁÆ¡¢Ò©Î↑·¢¼°È«Çò¿µ½¡ÖÎÀíÖÐʩչ¸ü½¹µã×÷Óᣡ£
×ÜÌåÀ´¿´£¬£¬ÓÐÈý¸ö·½ÃæÌØÕ÷¡£¡££¨1£©ÊÖÒÕÆÕ»Ý»¯£ºAI¹¤¾ßÖð²½±ê×¼»¯£¨ÈçPaigeÓëPathPresenterµÈƽ̨¼¯³É£©£¬£¬½µµÍʹÓÃÃż÷£¬£¬¼ÓËٶೡ¾°ÉøÍ¸¡£¡££¨2£©Õþ²ßÖ§³Ö£ºÅ·ÃËͨ¹ýEU4HealthµÈÍýÏë×ÊÖúÊý×Ö²¡ÀíÑз¢£¨Èç÷°ÂµÄRANGERÏîÄ¿£©£¬£¬FDA¼ÓËÙAI²¡Àí²úÆ·ÉóÅú£¨ÈçEpredia£©¡£¡££¨3£©ÐÂÐËÊг¡½á¹¹£ºÑÇÌ«µØÇø£¨ÈçÈÕ±¾NEC¡¢ÐÂ¼ÓÆÂMirxes£©¼Ó´ó°©Ö¢ÔçɸͶÈ룬£¬Á¬ÏµÍâµØ»¯²¡ÀíÊý¾Ý¿ª·¢¶¨ÖÆ»¯AIÄ£×Ó¡£¡£
£¨Ò»£©AIÇý¶¯µÄÊý×Ö²¡ÀíѧÊÖÒÕ¼ÓËÙÁ¢Òì
1. °©Ö¢¼ì²âÓ뾫׼ҽÁÆ
l NECÓëBiomyÏàÖú¿ª·¢AIÊý×Ö²¡ÀíÆ½Ì¨DeepPathFinder?£¬£¬Í¨Ì«¹ýÎöH&EȾɫͼÏñ¼ì²âÃâÒßϸ°û²¢Á¿»¯Ô¤ºóÌØÕ÷£¬£¬Ö¼ÔÚ·¢Ã÷ÐÂÉúÎï±ê¼ÇÎ£¬Ö§³Ö°©Ö¢¾«×¼ÖÎÁÆ¡£¡£
l PaigeÀ©Õ¹ÆäAI¼ì²â¹¤¾ß¡°PanCancer Detect¡±£¬£¬ÁýÕÖ40+Æ÷¹ÙÓëÓÐÊý°©Ö¢±äÌ壬£¬»ùÓÚ300ÍòÕŲ¡ÀíͼÏñѵÁ·µÄVirchow V2Ä£×ÓÏÔÖøÌáÉý¼ì²âѸËÙ¶È£¬£¬ÒÑÔÚÁÙ´²Ñо¿ÖÐÑéÖ¤ÆäÕï¶ÏÒ»ÖÂÐÔ¡£¡£
l AiosynÍÆ³öAIÖÊÁ¿¿ØÖƹ¤¾ßAiosynQC£¬£¬ÐÂÔö°×ƽºâ¼ì²â¹¦Ð§£¬£¬ÓÅ»¯Êý×Ö²¡ÀíͼÏñ׼ȷÐÔ£¬£¬ïÔÌÈ˹¤Ð£×¼ÐèÇ󣬣¬ÌáÉýÕï¶Ï¿É¿¿ÐÔ¡£¡£
2. »ù´¡Ä£×ÓÓëÊý¾ÝÕûºÏ
l ÷°ÂÕïËùÁªºÏNvidia¡¢Aignostics¹¹½¨»ùÓÚ2000ÍòÕŲ¡ÀíͼÏñµÄ»ù´¡Ä£×ÓAtlas£¬£¬Ö§³Ö¿ª·¢AIËã·¨ÓÃÓÚ°©Ö¢¼ì²âÓëÓÐÊý²¡Ñо¿£¬£¬Ä¿µÄ¼ÓËÙÒ©Îï·¢Ã÷ÓëÕï¶Ï¹¤¾ß¿ª·¢¡£¡£
l PathAIÓëDiscovery Life SciencesÏàÖú°²ÅÅAI²¡Ã÷È·¾ö¼Æ»®£¬£¬×Ô¶¯»¯²¡ÀíÆÀ¹ÀÁ÷³Ì²¢Ìṩ¶¨Á¿×éÖ¯ÆÊÎö£¬£¬ÖúÁ¦ÉúÎïÖÆÒ©ÆóÒµ¼ÓËÙÉúÎï±ê¼ÇÎï·¢Ã÷¡£¡£
1. ƽ̨»¯ÓëÉú̬¹¹½¨
l Myriad GeneticsÓëLumeaͨ¹ýBxLinkƽ̨ÕûºÏProlarisǰÏßÏÙ°©ºÍMyRiskÒÅ´«ÐÔ°©Ö¢¼ì²â£¬£¬ÊµÏÖµç×Ó»¯¶©¹ºÓëЧ¹û×·×Ù£¬£¬Ëõ¶ÌÕï¶ÏÖÜÆÚÖÁ10Ìì¡£¡£
l á⿨ÏÔ΢ϵͳÊÕ¹ºÓ«¹âȾÁϹ©Ó¦ÉÌATTO-TEC£¬£¬ÕûºÏÆä¸ßÐÔÄÜÓ«¹â±ê¼ÇÊÖÒÕ£¬£¬ÓÅ»¯ÏÔ΢¾µ³ÉÏñÁ÷³Ì£¬£¬Ö§³Ö°©Ö¢Ñо¿ÖеÄ3D³ÉÏñÓëAIÆÊÎö¡£¡£
2. î¿ÏµÓëÉÌÒµ»¯Í»ÆÆ
l EprediaµÄE1000 DxÊý×Ö²¡Àíϵͳ»ñFDA 510(k)ÈÏÖ¤£¬£¬³ÉΪÊ׸ö»ñÅúµÄÁÙ´²¼¶È«²£Æ¬³ÉÏñ¼Æ»®£¬£¬ÈÕ´¦Öóͷ£Á¿´ï1500Ñù±¾£¬£¬Ö§³Ö°©Ö¢Õï¶Ï±ê×¼»¯Óë¸ßЧ»¯¡£¡£
l LumeaÓëCaris Life SciencesÏàÖúÍÆ½øÃÚÄòÖ×Áö·Ö×ÓÆÊÎö£¬£¬½øÒ»²½À©Õ¹Êý×Ö²¡ÀíÆ½Ì¨ÔÚÁÙ´²ÖеÄÓ¦Óó¡¾°¡£¡£
1. ¸ß±¾Ç®ÓëͶ×ÊÃż÷
l áⲩ¿Æ±¨¸æÏÔʾ£¬£¬½ö33%µÄʵÑéÊÒʵÑéÊý×Ö²¡ÀíÍýÏ룬£¬³õʼװ±¸ÓëÊý¾Ý´æ´¢±¾Ç®£¨ÊýÊ®ÍòÖÁÊý°ÙÍòÃÀÔª£©ÊÇÖ÷ÒªÕϰ£¬£¬COVID-19ºó×ʽðǷȱ¼Ó¾çÁËÖÐС»ú¹¹µÄ½ÓÄÉÄѶȡ£¡£ÅàѵÐèÇó£ºÊµÑéÊÒÐèͶÈëÌØÊâ×ÊÔ´ÅàѵְԱʹÓÃAI¹¤¾ß£¬£¬½øÒ»²½ÍƸß×ܱ¾Ç®¡£¡£
2. ÊÖÒÕÓëÁ÷³Ì¹ßÐÔ
l ÏÖÓв¡ÀíÊÂÇéÁ÷³Ì³ÉÊ죬£¬²¿·ÖʵÑéÊÒ¶ÔAIÊÖÒյļÛÖµÈÏ֪ȱ·¦£¬£¬ÓÈÆäÔÚÌáÉýЧÂÊÓëÕï¶ÏÒ»ÖÂÐÔ·½ÃæÈ±·¦½ôÆÈÐÔ¡£¡£
l ÷°ÂÕïËùÖ¸³ö£¬£¬Ðèͨ¹ýÏÖʵ°¸Àý£¨ÈçAIïÔÌÎóÕïÂÊ£©Ö¤ÊµÊÖÒÕÓÅÊÆ£¬£¬²Å»ªÍƶ¯ÆÕ±é½ÓÄÉ¡£¡£
¶þ£¬£¬ADÕï¶ÏÈüµÀ
ADÕï¶ÏÊг¡ÕýÂÄÀú¡°ÑªÒº»¯¡¢¾«×¼»¯¡¢È«Çò»¯¡±×ªÐÍ£¬£¬·ÇÇÖÈëÐÔ¼ì²â£¨ÑªÒº¡¢ÄÔ¼¹Òº£©Öð²½Ìæ»»¹Å°åÓ°Ïñѧ£¬£¬³¬¸ßѸËÙ¶ÈÆ½Ì¨£¨Simoa¡¢NULISA£©Óë¶à×éѧÊý¾Ý£¨ADatlas£©³ÉΪÁ¢Òì½¹µã¡£¡£Ö»¹ÜÊÖÒÕÑéÖ¤Ó뱾ǮÌôÕ½ÈԴ棬£¬µ«î¿Ïµ¼ÓËÙ£¨FDA/MHRAÓÅÏÈÉóÅú£©Óë¿ç½çÏàÖú£¨Ñ§½ç-ÆóÒµ-»ù½ð»á£©ÎªÊг¡×¢È붯ÄÜ¡£¡£Î´À´£¬£¬ÅãͬÔçÆÚ»úÖÆÍ»ÆÆÓëÖÎÁÆÒ©ÎïÉÏÊУ¬£¬ADÕï¶Ï½«Ïòɸ²é¡¢·ÖÐͼ°ÁÆÐ§¼à²âÈ«Á´ÌõÑÓÉ죬£¬ÖØËÜÉñ¾ÍËÐÐÐÔ¼²²¡ÖÎÀí·¶Ê½¡£¡£
l ÊÖÒÕÑéÖ¤Óë±ê×¼»¯£ºÑªÒº±ê¼ÇÎïÐè½øÒ»²½ÑéÖ¤ÁÙ´²Ò»ÖÂÐÔ£¨ÈçC2NÓëPET±ÈÕÕÑо¿£©£¬£¬²¢½¨ÉèÈ«Çòͳһ¼ì²â±ê×¼¡£¡£
l ±¾Ç®Óë¿É¼°ÐÔ£ºPETɨÃè×°±¸ÌÚ¹ó£¨Ó¢¹úÊýÄ¿½öΪÃÀ¹ú1/10£©£¬£¬ÑªÒº¼ì²âµÄÆÕ¼°ÒÀÀµÒ½±£ÁýÕÖÓëϲãʵÑéÊÒÄÜÁ¦½¨Éè¡£¡£
l ÔçÆÚ¸ÉÔ¤»úÔµ£ºÕë¶ÔÓ¦¼¤¿ÅÁ£¡¢RNA±à¼µÈÔçÆÚ»úÖÆµÄÑо¿£¨ÈçÑÇÀûÉ£ÄÇÄ£×Ó£©»ò´ßÉúÔ¤·ÀÐÔÁÆ·¨£¬£¬Íƶ¯Õï¶Ï¹Ø¿ÚÇ°ÒÆ¡£¡£
1. ·ÇÇÖÈëÐÔÌæ»»¼Æ»®áÈÆð
l C2N DiagnosticsµÄPrecivityAD2ѪҺ¼ì²â»ñÓ¢¹úMHRAÅú×¼£¬£¬³ÉΪȫÇòÊ׸ö»ñÅúµÄADÌåÍâÕï¶ÏѪҺ²âÊÔ£¬£¬Í¨¹ý¼ì²âѪ½¬A¦Â42/A¦Â40¼°p-tau217/N-p-tau217±ÈÖµÆÀ¹Àµí·ÛÑùÂѰײ¡Àí£¬£¬±¾Ç®½öΪPETɨÃèµÄ1/10£¬£¬ÍýÏëÀ©Õ¹ÖÁÅ·ÖÞ¡¢Öж«µÈÊг¡¡£¡£
l Beckman Coulter£¨Danaher×Ó¹«Ë¾£©µÄAccess p-Tau217/¦Â-µí·ÛÑùÂѰ×1-42Ѫ½¬±ÈÖµ¼ì²â»ñFDAÍ»ÆÆÐÔ×°±¸È϶¨£¬£¬Á¬ÏµFujirebioÏàÖú¿ª·¢µÄÃâÒ߲ⶨ·¨£¬£¬ÎªADÕï¶ÏÌṩ¸ßѸËÙ¶ÈѪҺ¼ì²â¹¤¾ß¡£¡£
2. ³¬¸ßѸËÙ¶ÈÆ½Ì¨Á¢Òì
l Alamar Biosciences»ñADDF 1000ÍòÃÀԪͶ×Ê£¨ÀúÊ·×î´óµ¥±Ê£©£¬£¬ÆäNULISAƽ̨»ùÓÚÁÚλÅþÁ¬²â¶¨£¨PLA£©ÊÖÒÕ£¬£¬¿ÉʵÏÖ°¢ÍÐĦ¶û¼¶ÂѰ×Öʼì²â£¬£¬ÍýÏ뿪·¢Ê׸öADѪҺ¶à±ê¼ÇÎïÃæ°å£¬£¬Íƶ¯¾«×¼·ÖÐÍÓëÖÎÁƼà²â¡£¡£
l QuanterixµÄSimoaƽ̨ͨ¹ýµ¥·Ö×Ó¼ì²âÍ»ÆÆ¹Å°åѸËٶȼ«ÏÞ£¬£¬2025Äê½«ÍÆ³öSimoa1¶àÖØ¼ì²âϵͳ£¬£¬¾Û½¹Éñ¾Ñ×Ö¢ÓëÖ×ÁöѧӦÓ㬣¬²¢¼ÓËÙÈ«ÇòÕï¶ÏÍøÂç½á¹¹£¨ÐÂÔö10¸öÏàÖúͬ°é£©¡£¡£
1. ¶à×éѧÓë·Ö×Ó»úÖÆÍ»ÆÆ
l Ó¡µÚ°²ÄÉ´óѧÓëµÂ¿ËÈøË¹A&M´óѧ»ùÓÚ1460ÀýÄÔÑù±¾µÄRNA²âÐòÊý¾Ý£¬£¬·¢Ã÷AD»¼ÕßÖÐ25,351¸ö·Ç±àÂëRNA£¨ncRNA£©¼°53,763¸öת¼ºóÐÞÊΣ¨PTM£©Òì³££¬£¬½¨ÉèADatlasÊý¾Ý¿âÖ§³ÖÈ«ÇòÑо¿¡£¡£
l ÑÇÀûÉ£ÄÇÖÝÁ¢´óѧÌá³öADͳһģ×Ó£¬£¬Õ¹ÏÖϸ°ûºË-ϸ°ûÖÊÔËÊäϵͳ¹ÊÕϼ°ÂýÐÔÓ¦¼¤¿ÅÁ££¨²¶»ñ±ØÐè·Ö×Ó£©ÊÇADÔçÆÚÒªº¦Çý¶¯ÒòËØ£¬£¬Îª¸ÉÔ¤°ÐµãÌṩÐÂÆ«Ïò¡£¡£
2. AIÓëÊý¾Ýƽ̨¸³ÄÜ
l QuanterixÊÕ¹ºAkoya Biosciences£¬£¬ÕûºÏ¿Õ¼äÂѰ×ÖÊ×éѧÓ볬Ãô¼ì²âÊÖÒÕ£¬£¬¿ª·¢×éÖ¯-ѪҺÁªºÏÉúÎï±ê¼ÇÎïÊÔ¼ÁºÐ£¬£¬¼ÓËÙADÖÎÁÆÁÆÐ§¼à²â¡£¡£
l ÂÞÊϵĦµí·ÛÑùÂѰס¢×ÜTau¼°Á×ËữTau-181ÄÔ¼¹Òº¼ì²âÊÔ¼ÁºÐ½øÈëÖйúÒ©¼à¾ÖÓÅÏÈÉóÅúͨµÀ£¬£¬Ìî²¹º£ÄÚͬÀà²úÆ·¿Õȱ£¬£¬ÖúÁ¦ÁÙ´²¼±ÐèÕï¶Ï¹¤¾ßÂ䵨¡£¡£
1. ¿ç»ú¹¹ÏàÖúÓë×ʽð×¢Èë
l C2N Diagnostics»ñMichael J Fox»ù½ð»á150ÍòÃÀÔªÔù¿î£¬£¬ÁªºÏÑо¿ADÓëÅÁ½ðɲ¡¡¢Â·Ò×Ìå³Õ´ôµÄ¦Á-Í»´¥ºËÂѰ׹ØÁª£¬£¬À©Õ¹PrecivityAD2ÔÚÉñ¾ÍËÐÐÐÔ¼²²¡ÖеÄÓ¦Óó¡¾°¡£¡£
l ADDFÕï¶Ï¼ÓËÙÆ÷ÀÛ¼ÆÍ¶È볬3.6ÒÚÃÀÔª£¬£¬Ö§³ÖÈ«Çò760+ÏîÄ¿£¬£¬Íƶ¯Ê׸öADѪҺ¼ì²â£¨PrecivityAD?£©¼°PETʾ×Ù¼Á£¨Amyvid?£©ÉÌÒµ»¯£¬£¬Ò»Á¬½á¹¹ÔçÆÚ¼ì²â¹¤¾ß¡£¡£
2. È«Çò»¯Êг¡½á¹¹
l QuanterixÍýÏëͨ¹ýLucent DiagnosticsʵÑéÊÒ¿ª·¢ÎåÁªÉúÎï±ê¼ÇÎï¼ì²â£¬£¬½«Õï¶ÏÖÐÐÄÇøÎó²î´Ó30%½µÖÁ10%£¬£¬²¢ÓëPET/ÄÔ¼¹Òº¼ì²â¶Ô±ê£¬£¬Ä¿µÄʵÏÖAD¼ì²â³£Ì¬»¯£¨È絨¹Ì´¼¼ì²â£©¡£¡£
l ÂÞÊÏÓëC2Nͨ¹ýÓÅÏÈÉóÅú¼°ÍâÑóÏàÖú£¨ÈçUnilabs£©£¬£¬¼ÓËÙADÕï¶Ï¹¤¾ßÔÚÐÂÐËÊг¡µÄÉøÍ¸£¬£¬Ó¦¶ÔÀÏÁ仯´øÀ´µÄÒ½ÁƼ縺¡£¡£
Èý£¬£¬²âÐòÈüµÀ
ÄÉÃ׿×ÓëÀ©ÔöÊÖÒÕÌôÕ½¹Å°å¶Ì¶Á³¤°ÔȨ£¬£¬¸ßͨÁ¿¡¢³¤¶Á³¤Óë¶à×éѧÕûºÏ³ÉΪ½¹µãÇ÷ÊÆ£¬£¬ÖÐͨÁ¿×°±¸Ìî²¹ÎÞаÐèÇóȱ¿Ú£¬£¬µØÔµÕþ²ßÖØËÜÊг¡ÃûÌᣡ££¨1£©ÊÖÒÕ±ê×¼»¯£º³¤¶Á³¤²âÐò£¨ÈçSBX¡¢Oxford Nanopore£©Ðè½øÒ»²½ÑéÖ¤ÁÙ´²Ò»ÖÂÐÔ£¬£¬¶Ì¶Á³¤ÊÖÒÕ£¨Illumina£©ÈÔÖ÷µ¼´ó¹æÄ£Ó¦Óᣡ££¨2£©±¾Ç®Óë¿É¼°ÐÔ£ºÖÐͨÁ¿×°±¸£¨DNBSeq-T1+£©¼ò»¯ÊÂÇéÁ÷³Ì£¬£¬µ«Êг¡ÉøÍ¸ÒÀÀµÐÔ¼Û±ÈÓëÍâµØ»¯Ð§ÀÍÄÜÁ¦¡£¡££¨3£©¶à×éѧÕûºÏ£ºÔλ²âÐò£¨Element£©¡¢¿Õ¼äת¼×éѧ£¨Illumina£©ÓëÂѰ×Öʼì²â£¨Quanterix£©Èںϣ¬£¬Íƶ¯¾«×¼Ò½Ñ§Ïòϸ°û¼¶Çø·ÖÂÊÂõ½ø¡£¡£
1. ¸ßͨÁ¿µ¥Ï¸°û²âÐò
l Parse Biosciences ÍÆ³ö Evercode WT Penta ÊÔ¼ÁºÐ£¬£¬µ¥´ÎÔËÐÐ¿ÉÆÊÎö500Íò¸öϸ°ûºÍ384¸öÑù±¾£¬£¬Í»ÆÆµ¥Ï¸°û²âÐòͨÁ¿¼«ÏÞ£¬£¬ÖúÁ¦ÓÐÊýϸ°ûÀàÐÍʶ±ðÓë´ó¹æÄ£Ò©Îïɸѡ¡£¡£
l Illumina Óë Broad Clinical Labs ÏàÖúÆô¶¯ 50ÒÚϸ°ûͼÆ×ÍýÏ룬£¬Ê¹ÓÃNovaSeq X Plusƽ̨¼ÓËÙ¼²²¡½¨Ä£ÓëÒ©Î↑·¢¡£¡£
2. ÄÉÃ׿×ÓëÀ©Ôö²âÐòÊÖÒÕ
l ÂÞÊÏÍýÏë2026ÄêÍÆ³ö SBXÄÉÃ׿ײâÐòƽ̨£¬£¬»ùÓÚXpandomer·Ö×ÓÀ©ÔöÊÖÒÕ£¬£¬ÊµÏָ߾«¶È£¨SNV׼ȷÂÊ>99.8%£©¡¢³¬¸ßͨÁ¿£¨1СʱÍê³É7¸öÈ«»ùÒò×é²âÐò£©¼°ÎÞа¶Á³¤£¨50bp-1000bp£©£¬£¬ÔçÆÚÏàÖúÕß°üÀ¨Hartwigҽѧ»ù½ð»áºÍBroadÑо¿Ëù¡£¡£
l Oxford Nanopore 2024ÄêÊÕÈëÔöÌí8%£¨½¹µãÓªÒµÔöÌí20%£©£¬£¬PromethIon²úÆ·ÏßÊÕÈëÔöÌí31%£¬£¬µ«Êܰ¢ÁªÇõ»ùÒò×éÍýÏëÊÕÈëÏ»¬ÍÏÀÛ¡£¡£
3. ¶à×éѧÓë±ãЯ»¯×°±¸
l Element Biosciences Ðû²¼ Aviti24 ¶à×éѧƽ̨õ辶ͼ£¬£¬ÐÂÔöÔλRNA²âÐò£¨DiSSÊÖÒÕ£©ÓëFFPE×éÖ¯¼æÈݹ¦Ð§£¬£¬Ä¿µÄÓ¦ÓÃÓÚÃâÒßÖ×ÁöѧÓëÉñ¾¿ÆÑ§Ñо¿¡£¡£
l Complete Genomics ÍÆ³ö DNBSeq-T1+ÖÐͨÁ¿²âÐòÒÇ£¬£¬Ö§³Ö24СʱÄÚÍê³ÉË«¶Ë150bp²âÐò£¬£¬Êý¾Ý±¾Ç®µÍÖÁ2.5ÃÀÔª/Gb£¬£¬¶Ô±êIllumina NovaSeqÐÔÄÜ¡£¡£
1. ÆóÒµÌåÏÖ·Ö½â
l Pacific Biosciences 2024ÄêÊÕÈëϽµ23%£¬£¬µÚËÄÐò¶ÈÒÇÆ÷ÊÕÈëÈñ¼õ56%£¬£¬µ«Vegąʽ²âÐòÒdzö»õÁ¿Öð²½ÌáÉý£¬£¬ÁÙ´²Õ½ÂÔÒ»Á¬Íƽø¡£¡£
l Oxford Nanopore ÔÚ¹¤ÒµÓ¦Óã¨ÊÕÈëÔöÌí42%£©ÓëÉúÎïÖÆÒ©£¨ÔöÌí18%£©ÁìÓòÌåÏÖÇ¿¾¢£¬£¬µ«¾»¿÷ËðÈÔ´ï1.46ÒÚÓ¢°÷£¬£¬ÒÀÀµÑз¢Í¶ÈëÇý¶¯Á¢Òì¡£¡£
2. µØÔµÕþÖÎΣº¦¼Ó¾ç
l Öйú½« Illumina ÁÐÈë²»¿É¿¿ÊµÌåÇåµ¥£¬£¬Õ¥È¡Æä»ùÒò²âÐòÒǶԻª³ö¿Ú£¬£¬Îª±¾ÍÁÆóÒµ£¨È绪´óÖÇÔ죩´´Á¢Êг¡»úÔµ¡£¡£
l Complete Genomics ÒÀ¸½DNBSeq-T1+ÓëE25 Flash±ãЯ²âÐòÒÇ£¬£¬¼ÓËÙÇÀÕ¼ÖÐͨÁ¿Êг¡£¬£¬Í¬Ê±ÃæÁÙÊÖÒÕÑéÖ¤ÓëµØÔµÕþ²ßË«ÖØÌôÕ½¡£¡£
1. ²úѧÑÐÁª¶¯
l AvestagenomeÏîÄ¿Óë TIGS ÏàÖú£¬£¬Ê¹ÓÃÓ¡¶ÈÅÁÎ÷ÉçÇø4700·ÝÑù±¾Ñо¿ÓÐÊý²¡ÒÅ´«Ñ§£¬£¬Ì½Ë÷mRNAÁÆ·¨Óë»ùÒòÖÎÁÆÇ±Á¦¡£¡£
l ÂÞÊÏͨ¹ý SBXƽ̨¹¹½¨¿ª·Å²âÐòÉú̬ϵͳ£¬£¬¼æ¹Ë¿ÆÑÐÓëÁÙ´²ÐèÇ󣬣¬ÍýÏëÓë¼ì²âÊÔ¼ÁºÐÕûºÏÐγɶ˵½¶Ë½â¾ö¼Æ»®¡£¡£
2. ÊÖÒÕ»¥²¹ÐÔÏàÖú
l Quanterix ÊÕ¹º Akoya Biosciences£¬£¬ÕûºÏ¿Õ¼äÂѰ×ÖÊ×éѧÓ볬ÃôSimoa¼ì²âÊÖÒÕ£¬£¬¿ª·¢Ö×Áö¼à²â¹¤¾ß¡£¡£
l Element Biosciences Óë TGen ÏàÖúÓÅ»¯Aviti24ƽ̨£¬£¬Ö§³ÖÖØ´óÑù±¾£¨ÈçFFPE£©ÆÊÎö£¬£¬ÍØÕ¹ÖÆÒ©Ó¦Óó¡¾°¡£¡£
¸´ºÏÐÍ¡¢¿çÐÐÒµÂÄÀú¸ß¹Ü»ñÌáÉýÒ»ºÅλ
IVDÐÐÒµ¸ß¹Ü±ä»»·ºÆð¡°ÇøÓò»¯¡¢ÉÌÒµ»¯¡¢ÊÖÒÕ»¯¡±Èý´óÖ÷Ïß¡£¡£ÐÂÈÎÏòµ¼Õß¶à¾ß±¸¿çÐÐÒµÂÄÀú£¬£¬Íƶ¯ÆóÒµ´Ó²úÆ·¿ª·¢ÏòÊг¡ÉøÍ¸¡¢´Ó¼òµ¥Õï¶ÏÏò¶àÊÖÒÕÈںϵĿçÔ½¡£¡££¨1£©ÇøÓòÉî¸û£º¼ÑÄÜÒ½ÁÆ¡¢ÑÅÅàÖйúµÄÈËÊÂÇ黻͹ÏÔ¿ç¹úÆóÒµ¶ÔÖйúÊг¡µÄºã¾ÃͶÈ룬£¬Á¬ÏµÍâµØ»¯Õ½ÂÔÓ¦¶ÔÒ½ÁÆÐèÇóÉý¼¶¡£¡££¨2£©ÉÌÒµ»¯Çý¶¯£ºCofactor Genomics¡¢NeoGenomicsµÄ¸ß¹Üµ÷½â·´Ó¦ÆóÒµ´ÓÊÖÒÕÑз¢Ïò¹æÄ£»£»£»¯ÉÌÒµÂ䵨µÄתÐÍÐèÇ󡣡££¨3£©ÊÖÒÕÕûºÏ£ºLGCÓëSapio SciencesµÄÈÎÃüÅú×¢£¬£¬AIÓë¶à×éѧÊÖÒÕÕý³ÉΪIVDÐÐÒµÁ¢Òì½¹µã£¬£¬¸ß¹ÜÅä¾°¶à¾Û½¹¿çÁìÓò×ÊÔ´ÕûºÏÄÜÁ¦¡£¡£
1. ¼ÑÄÜÒ½ÁÆ£¨Canon Medical£©
l Wataru Taguchi£¨ÔÈ«ÇòÖ´Ðи±×ܲ㩱»ÈÎÃüΪÖйú×Ü´ú±í£¬£¬ÈÏÕæÕ½ÂÔÍýÏëÓëÓªÒµÕûºÏ£¬£¬ÒÀ¸½ÆäÈ«ÇòÔËÓªÂÄÀúÍÆ¶¯ÖйúÊг¡µÄÒ»Á¬ÔöÌí¡£¡£
l Katsuya Takao£¨ÓµÓÐ34Ä깫˾ÂÄÀú£©³öÈÎÖйúÇø×ܲüæCEO£¬£¬×¨×¢ÓªÏúÓëЧÀÍÀ©Õ¹£¬£¬Æä¿çÎÄ»¯Åä¾°½«ÖúÁ¦¼ÑÄÜÒ½ÁÆÉ±¾ÍÁ»¯½á¹¹¡£¡£ËûÔÚCanon MedicalÓÐ34ÄêÂÄÀú£¬£¬ÔøÔÚÈÕ±¾¡¢ÐÂ¼ÓÆÂºÍºÉÀ¼µ£µ±¸ß¼¶Ö°Îñ¡£¡£
l Åä¾°£º´Ë´ÎÈËʵ÷½âÕýÖµ¼ÑÄÜÒ½ÁÆÔÚ»ªÔËÓª50ÖÜÄ꣬£¬Ö¼ÔÚÌáÉýÒ½ÁÆÐ§ÀÍÖÊÁ¿Óë¿É¼°ÐÔ£¬£¬Ö§³ÖÖйúÒ½ÁÆ¿µ½¡ÁìÓò¿ìËÙÉú³¤¡£¡£
2. ÑÅÅàÖйú£¨Abbott£©
l Fanny Chen£¨³ÂÓ£©£¨½¹µãÕï¶Ï×ܲã©Ðû²¼ÍËÐÝ£¬£¬ÆäÔÚÑÅÅàÈÎÖ°23Ä꣬£¬ÔøÖ÷µ¼¹©Ó¦Á´ÓÅ»¯ÓëÕ½ÂÔ¹ØÏµÖÎÀí¡£¡£
l Tan Paul£¨Ì·Ãô½Ü£©½ÓÈÎÈ«Çò¸±×ܲüæÖйú½¹µãÕï¶Ï×ܲ㬣¬ËûÓÚ2014Äê¼ÓÈëÑÅÅ༯ÍÅ£¬£¬´Ëǰµ£µ±ÑÅÅàÐÄѪ¹ÜÓªÒµ²¿·Ö¸±×ܲᢴóÖлªÇø×Ü˾ÀíµÈÖ°¡£¡£
1. Cofactor Genomics
l Chris Parker£¨Ç°AdelaÊ×ϯÉÌÎñ¹Ù£©½ÓÈÎCEO£¬£¬Ê×´´ÈËJarret GlasscockתÈÎ×ܲüæCTO¡£¡£ParkerÔøÏòµ¼Exact SciencesÓªÒµ¿ª·¢£¬£¬´Ë´Îµ÷½âÖ¼ÔÚ¼ÓËÙÉÌÒµ»¯Àú³Ì£¬£¬À©´óÃâÒßÖÎÁÆÅãͬÕï¶Ï²úÆ·£¨OncoPrism£©µÄÊг¡ÁýÕÖ£¬£¬¸Ã¼ì²âÒÑ»ñÃÀ¹úÒ½±£ÁýÕÖ¡£¡£
2. NeoGenomics
l Chris Smith£¨CEO£©½«ÓÚ2025Äê4ÔÂÍËÐÝ£¬£¬ÆäÈÎÆÚÄÚ¹«Ë¾ÊµÏÖÒ»Á¬8¸ö¼¾¶ÈÁ½Î»ÊýÊÕÈëÔöÌí£¬£¬²¢Å¤¿÷Ϊӯ£¨2024ÄêEBITDAÔ¤ÆÚ´ï3700-4000ÍòÃÀÔª£©¡£¡£
l Tony Zook£¨Ç°°¢Ë¹Àû¿µÈ«ÇòÉÌÒµÈÏÕæÈË£©½ÓÈÎCEO£¬£¬ÆäÉÌÒµ»¯ÂÄÀú»òÍÆ¶¯Ö×Áö¼ì²âÓªÒµµÄÈ«ÇòÀ©ÕÅ£¬£¬ÌØÊâÊÇÉúÎïÖÆ¼ÁÓ뾫׼ҽÁÆÁìÓò¡£¡£
1. BD£¨±ÌµÏÒ½ÁÆ£©
l Pamela Spikner£¨Ç°R1 RCMÊ×ϯ»á¼Æ¹Ù£©±»ÈÎÃüΪÊ×ϯ»á¼Æ¹Ù¼æ²ÆÎñ×ܼ࣬£¬ÈÏÕæ²ÆÎñ±¨¸æÓëºÏ¹æ£¬£¬ÆäÒ½ÁÆÐÐÒµÉó¼ÆÅä¾°½«Ç¿»¯BDµÄ²ÆÎñÕ½ÂÔÓëÔËӪЧÂÊ¡£¡£Ëý´ËǰÔÚR1 RCM, Inc.µ£µ±Ê×ϯ»á¼Æ¹Ù£¬£¬ÔÚExelon CorporationÓÐ12Äê»á¼ÆÏòµ¼Ö°ÎñÂÄÀú¡£¡£
2. LGC¼¯ÍÅ
l Joydeep Goswami£¨IlluminaǰCFO¡¢Ê×ϯսÂÔ¹Ù¡¢ÆóÒµÉú³¤¹Ù£©³öÈÎCEO£¬£¬ÆäÈüĬ·ÉÊÀ¶û16ÄêÂÄÀú£¨Ïòµ¼NGSÓëÖ×Áö²¿·Ö£©¼°²¢¹º×¨³¤£¬£¬»òÍÆ¶¯LGCÔÚÉúÃü¿ÆÑ§¹¤¾ßÁìÓòµÄÊÖÒÕÕûºÏÓëÊг¡ÍØÕ¹¡£¡£
3. Sapio Sciences
l Mike Hampton£¨Ç°IDBS¸ß¹Ü£©µ£µ±Ê×ϯÉÌÎñ¹Ù£¬£¬Ö÷µ¼È«ÇòÉÌÒµÕ½ÂÔºÍÔËÓª£¬£¬×ÅʵÑéÊÒÐÅϢѧÅä¾°½«¼ÓËÙAIÇý¶¯µÄÒ©Îï·¢Ã÷ƽ̨ӦÓᣡ£Ëû´ËǰÔÚIDBSÓÐÁè¼Ý¶þÊ®ÄêµÄÂÄÀú¡£¡£
l Rob BrownÌáÉýΪ¿ÆÑ§°ì¹«ÊÒÈ«Çò¸±×ܲ㬣¬ÈÏÕæ¿ª·¢AI½â¾ö¼Æ»®£¬£¬ÓÅ»¯ÉúÎïÖÆÒ©Ñз¢ÓëÕï¶ÏÊÂÇéÁ÷³Ì¡£¡£
±¾ÍøÕ¾ÄÚËùÓÐ×ÊѶ¼°ËزĽö¹©Ñ§Ï°Óë¿ÆÆÕ¡£¡£ÈçͼƬºÍËØ²Ä°æÈ¨ÓµÓÐÕß·¢Ã÷×Ô¼º×÷Æ·±»ÇÖȨ£¬£¬ÇëʵʱÏòÓÀöιú¼ÊÒ½ÁÆÌá³öȨÁ¦Í¨Öª£¬£¬ÓÀöιú¼ÊÒ½ÁÆÔÚÊÕµ½Ïà¹ØÍ¨Öªºó£¬£¬24СʱÄÚÒÆ³ýÏà¹ØÉæÏÓÇÖȨµÄÄÚÈÝ¡£¡£